Catestatin and Hypertension in Pregnancy

NCT03200743 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-06-27

No results posted yet for this study

Summary

Catestatin is a kind of protein involved with cardiovascular disease. Accumulated evidence shows that Catestatin may be a predictor of primary hypertension, but whether it plays the same role in pregnant hypertensive disorders needs to be determined. By measuring the plasma level of Catestatin, main biochemical marks and UCG in healthy pregnancy and pregnancy with hypertension, the research may contribute to this problem.

Conditions

  • Pre-Eclampsia
  • Eclampsia
  • Hypertension, Pregnancy-Induced
  • Hypertension in Pregnancy

Sponsors & Collaborators

  • Yuchen Pan

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-14
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03200743 on ClinicalTrials.gov